Search

In recent years, Raman spectroscopy has been used to study biological tissues. However, the analysis of experimental Raman spectra is still challenging, since the Raman spectra of most biological tissue components overlap significantly and it is difficult to separate individual components. New methods of analysis are needed that would allow for the decomposition of Raman spectra into components and the evaluation of their contribution. The aim of our work is to study the possibilities of the multivariate curve resolution alternating least squares (MCR-ALS) method for the analysis of skin tissues in vivo. We investigated the Raman spectra of human skin recorded using a portable conventional Raman spectroscopy setup. The MCR-ALS analysis was performed for the Raman spectra of normal skin, keratosis, basal cell carcinoma, malignant melanoma, and pigmented nevus. We obtained spectral profiles corresponding to the contribution of the optical system and skin components: melanin, proteins, lipids, water, etc. The obtained results show that the multivariate curve resolution alternating least squares analysis can provide new information on the biochemical profiles of skin tissues. Such information may be used in medical diagnostics to analyze Raman spectra with a low signal-to-noise ratio, as well as in various fields of science and industry for preprocessing Raman spectra to remove parasitic components.

In this study, patient data were combined with Raman and autofluorescence spectral parameters for more accurate identification of skin tumors. The spectral and patient data of skin tumors were classified by projection on latent structures and discriminant analysis. The importance of patient risk factors was determined using statistical improvement of ROC AUCs when spectral parameters were combined with risk factors. Gender, age and tumor localization were found significant for classification of malignant versus benign neoplasms, resulting in improvement of ROC AUCs from 0.610 to 0.818 (p < 0.05). To distinguish melanoma versus pigmented skin tumors, the same factors significantly improved ROC AUCs from 0.709 to 0.810 (p < 0.05) when analyzed together according to the spectral data, but insignificantly (p > 0.05) when analyzed individually. For classification of melanoma versus seborrheic keratosis, no statistical improvement of ROC AUC was observed when the patient data were added to the spectral data. In all three classification models, additional risk factors such as occupational hazards, family history, sun exposure, size, and personal history did not statistically improve the ROC AUCs. In summary, combined analysis of spectral and patient data can be significant for certain diagnostic tasks: patient data demonstrated the distribution of skin tumor incidence in different demographic groups, whereas tumors within each group were distinguished using the spectral differences.